Biotechnology Stocks II Performance Guide:Mineralys Therapeutics, Inc. (MLYS)

Biotechnology Stocks II Performance Guide: Mineralys Therapeutics, Inc. (MLYS)

MLYS has no dividends.

Table and Chart of MLYS Performance

See what a $1,000 investment in MLYS is worth today.

Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.

MLYS Returns
Start DateMar-31-2023
Start Price$15.66
End DateJul-19-2024
End Price$13.20
# Prices17
Min DateNov-30-2023
Min Price$6.66
Max DateJun-30-2023
Max Price$17.05
Total Return-15.71%
Annualized Return-11.36%
Current Value of $1,000 Purchase$843
Number Returns136
Average Return0.34%
Number Profitable Returns52
Percent Profitable Returns38.24%
Number Unprofitable Returns84
Percent Unprofitable Returns61.76%
Profitable to Unprofitable Returns Ratio0.62



MLYS Data
VALUATION DATA
Market Capitalization$562,518,000
Beta
Price to Sales
Earnings per Share$-2.1800
PE RatioNone
PE to Growth RatioNone
Price to Book2.671
PRICE DATA
52 Week High$16.91
52 Week Low$5.85
Analyst Target Price$33.5
50-Day Moving Average$12.59
200-Day Moving Average$10.9
FINANCIAL DATA
Revenue per Share$0
Revenue$0
Profit Margin0%
Return on Equity-29.1%
Stock Dividend, Valuation, Price and Financial Data Input

Previous Stock  TOC  Next Stock

MLYS Dollar-cost Average

MLYS Compare Returns with S&P 500

MLYS Trendline Chart

MLYS Moving Average Chart

MLYS Stock Return Map - See Patterns of Gains and Losses

MLYS Stock Returns/Purchase Dates